Profound Medical (PROF) Other Non-Current Liabilities (2018 - 2026)
Profound Medical's (PROF) quarterly Other Non-Current Liabilities came in at $92000.0 in Q1 2026, up 27.78% year-on-year from $72000.0 in Q1 2025, and up 16.46% quarter-over-quarter from $79000.0 in Q4 2025.
Profound Medical (PROF) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Profound Medical's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $92000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 27.78% year-over-year to $92000.0 in Q1 2026; TTM through Mar 2026 was $92000.0, a 27.78% increase from a year earlier, with the FY2025 full-year figure at $79000.0, up 11.27% from the prior year.
- Other Non-Current Liabilities advanced to $92000.0 in Q1 2026 per PROF's latest filing, from $79000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $92000.0 in Q1 2026 and bottomed at $71000.0 in Q4 2024.
- The 4-year median for Other Non-Current Liabilities is $76000.0 (2025), against an average of $77142.9.
- Across the five-year window, Other Non-Current Liabilities declined 2.74% in 2024 and gained 27.78% in 2026, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $73000.0 in 2023, then retreated by 2.74% to $71000.0 in 2024, then increased by 11.27% to $79000.0 in 2025, then climbed by 16.46% to $92000.0 in 2026.
- Per Business Quant, the three latest PROF Other Non-Current Liabilities figures stand at $92000.0 (Q1 2026), $79000.0 (Q4 2025), and $76000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92,000.00 |
| Dec 31, 2025 | 79,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 77,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Dec 31, 2023 | 73,000.00 |
| Dec 31, 2020 | 99,000.00 |
| Dec 31, 2019 | 217,294.46 |
| Jan 1, 2019 | 733,000.00 |
| Dec 31, 2018 | 757,735.71 |